Pancréatites d'origine médicamenteuse. Revue des notifications spontanées en France

L. Chebane (1) , H. Bagheri (1) , D. Hillaire-Buys (2) , H. Géniaux , N. Yahioui , M.-L. Laroche , J. Cottin , A. Spreux , B. Mosquet , C. Pecriaux , F. Bellet (3) , A. Lambert (4) , J.-L. Montastruc

1 LEASP - Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
3 AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris]
4 Service Pharmacologie Clinique [CHU Toulouse]

Identify the main pharmacological classes inducing pancreatitis using spontaneous reports recorded in the French pharmacovigilance database (FPVD). Cases of pancreatitis recorded in FPVD between January 1st 1985 and December 31st 2013 were selected using the 2001 consensus conference criteria of the French High Health Authority. During this period, 2975 observations were selected with 1151 fulfilling criteria of drug-induced pancreatitis (i.e. 0.22% of total notifications in the FPVD). According to ATC classification, the pharmacological classes most frequently found were antiretroviral, analgesic, lipid-lowering, immunosuppressive and insulin secreting drugs. For some drugs (metformin, omeprazole, etc.) pancreatitis was "unlabelled" in the summary of product characteristics. This review allows to identify the main drug classes currently involved in spontaneous reporting of pancreatitis in France.

Domaines: Sciences du Vivant [q-bio]

L. Chebane, H. Bagheri, D. Hillaire-Buys, H. Géniaux, N. Yahioui, et al.. Pancréatites d'origine médicamenteuse. Revue des notifications spontanées en France. La Revue de Médecine Interne, 2015, 36 (9), pp.573--578. ⟨hal-01987726⟩